Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser

Eur J Dermatol. 2023 Aug 1;33(4):428-430. doi: 10.1684/ejd.2023.4513.

Authors

Kaori Murakami¹, Yasuko Saito¹, Sakiko Takeuchi¹, Kasuyu Sujino¹, Akiko Tanikawa¹, Kenji Tanese¹, Keitaro Fukuda²

Affiliations

¹ Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
² Department of Dermatology, Keio University School of Medicine, Tokyo, Japan, Laboratory for Skin Homeostasis, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

PMID: 37823495
DOI: 10.1684/ejd.2023.4513

No abstract available

MeSH terms

Alopecia Areata* / drug therapy
Humans
Hypopigmentation*
Lasers, Excimer / therapeutic use
Treatment Outcome
Vitiligo* / complications
Vitiligo* / therapy

Substances

delgocitinib

Supplementary concepts

Diffuse alopecia